Medifast Inc (MED) stock
MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 10/3064% below fair value
$12.97+0.11 (+0.86%)
Close on Nov 13, 2026Market cap $145.04MP/E –Yield 0.00%
Medifast gross margin
Gross margin is gross profit as a percentage of revenue.
Medifast's gross margin for the twelve months ending Sep 30, 2026 was 69.2%. For fiscal 2025 it was 71.3%, against 73.8% the year before. The highest annual figure on record is 75.8% in fiscal 2018.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 71.3% | −2.5 |
| FY2024 | Dec 31, 2024 | 73.8% | +1.4 |
| FY2023 | Dec 31, 2023 | 72.4% | +1.0 |
| FY2022 | Dec 31, 2022 | 71.3% | −2.5 |
| FY2021 | Dec 31, 2021 | 73.9% | −0.8 |
| FY2020 | Dec 31, 2020 | 74.6% | −0.6 |
| FY2019 | Dec 31, 2019 | 75.2% | −0.6 |
| FY2018 | Dec 31, 2018 | 75.8% | +0.3 |
| FY2017 | Dec 31, 2017 | 75.5% | +0.6 |
| FY2016 | Dec 31, 2016 | 74.9% | +1.1 |
| FY2015 | Dec 31, 2015 | 73.8% | +0.5 |
| FY2014 | Dec 31, 2014 | 73.3% | −0.9 |
| FY2013 | Dec 31, 2013 | 74.2% | +0.2 |
| FY2012 | Dec 31, 2012 | 74.1% | −1.2 |
| FY2011 | Dec 31, 2011 | 75.3% | +0.6 |
| FY2010 | Dec 31, 2010 | 74.7% | +1.4 |
| FY2009 | Dec 31, 2009 | 73.3% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 69.5% | −0.1 |
| Q2 FY2026 | Jun 30, 2026 | 69.9% | −2.7 |
| Q1 FY2026 | Mar 31, 2026 | 68.1% | −4.7 |
| Q4 FY2025 | Dec 31, 2025 | 69.4% | −4.7 |
| Q3 FY2025 | Sep 30, 2025 | 69.5% | −5.9 |
| Q2 FY2025 | Jun 30, 2025 | 72.6% | −0.6 |
| Q1 FY2025 | Mar 31, 2025 | 72.8% | −0.1 |
| Q4 FY2024 | Dec 31, 2024 | 74.1% | +0.1 |
| Q3 FY2024 | Sep 30, 2024 | 75.4% | +0.2 |
| Q2 FY2024 | Jun 30, 2024 | 73.2% | +2.1 |
| Q1 FY2024 | Mar 31, 2024 | 72.8% | +2.2 |
| Q4 FY2023 | Dec 31, 2023 | 74.0% | +4.7 |
| Q3 FY2023 | Sep 30, 2023 | 75.2% | +2.8 |
| Q2 FY2023 | Jun 30, 2023 | 71.1% | +0.2 |
| Q1 FY2023 | Mar 31, 2023 | 70.6% | −1.8 |
| Q4 FY2022 | Dec 31, 2022 | 69.3% | −4.4 |
| Q3 FY2022 | Sep 30, 2022 | 72.5% | −1.8 |
| Q2 FY2022 | Jun 30, 2022 | 71.0% | −3.5 |
| Q1 FY2022 | Mar 31, 2022 | 72.4% | −0.6 |
| Q4 FY2021 | Dec 31, 2021 | 73.7% | −1.6 |
| Q3 FY2021 | Sep 30, 2021 | 74.3% | −0.9 |
| Q2 FY2021 | Jun 30, 2021 | 74.5% | +2.1 |
| Q1 FY2021 | Mar 31, 2021 | 73.0% | −2.8 |
| Q4 FY2020 | Dec 31, 2020 | 75.2% | +0.2 |
| Q3 FY2020 | Sep 30, 2020 | 75.2% | −0.0 |
| Q2 FY2020 | Jun 30, 2020 | 72.4% | −2.8 |
| Q1 FY2020 | Mar 31, 2020 | 75.8% | +0.3 |
| Q4 FY2019 | Dec 31, 2019 | 75.1% | +0.3 |
| Q3 FY2019 | Sep 30, 2019 | 75.2% | −1.8 |
| Q2 FY2019 | Jun 30, 2019 | 75.2% | −0.5 |
| Q1 FY2019 | Mar 31, 2019 | 75.4% | −0.4 |
| Q4 FY2018 | Dec 31, 2018 | 74.8% | −1.0 |
| Q3 FY2018 | Sep 30, 2018 | 77.0% | +1.6 |
| Q2 FY2018 | Jun 30, 2018 | 75.7% | −0.4 |
| Q1 FY2018 | Mar 31, 2018 | 75.9% | +1.0 |
| Q4 FY2017 | Dec 31, 2017 | 75.8% | +0.4 |
| Q3 FY2017 | Sep 30, 2017 | 75.4% | – |
| Q2 FY2017 | Jun 30, 2017 | 76.1% | – |
| Q1 FY2017 | Mar 31, 2017 | 74.9% | – |
| Q4 FY2016 | Dec 31, 2016 | 75.4% | – |
See a number that looks wrong?